T

Transcenta Holding Limited
HKEX:6628

Watchlist Manager
Transcenta Holding Limited
HKEX:6628
Watchlist
Price: 1.76 HKD Market Closed
Updated: May 29, 2024

Transcenta Holding Limited
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Transcenta Holding Limited
Operating Expenses Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
T
Transcenta Holding Limited
HKEX:6628
Operating Expenses
-¥459.8m
CAGR 3-Years
-12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Operating Expenses
-¥23.5B
CAGR 3-Years
-22%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Operating Expenses
-¥6.5B
CAGR 3-Years
-19%
CAGR 5-Years
-34%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Operating Expenses
-¥3.1B
CAGR 3-Years
-41%
CAGR 5-Years
-42%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Operating Expenses
-¥4.8B
CAGR 3-Years
-35%
CAGR 5-Years
-32%
CAGR 10-Years
-30%
Imeik Technology Development Co Ltd
SZSE:300896
Operating Expenses
-¥458.8m
CAGR 3-Years
-38%
CAGR 5-Years
-36%
CAGR 10-Years
N/A

See Also

What is Transcenta Holding Limited's Operating Expenses?
Operating Expenses
-459.8m CNY

Based on the financial report for Dec 31, 2023, Transcenta Holding Limited's Operating Expenses amounts to -459.8m CNY.

What is Transcenta Holding Limited's Operating Expenses growth rate?
Operating Expenses CAGR 3Y
-12%

Over the last year, the Operating Expenses growth was -5%. The average annual Operating Expenses growth rates for Transcenta Holding Limited have been -12% over the past three years .